# Oncolytics Biotech (ONCY) — Earnings

ONCY · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/oncy/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.10 |
| EPS estimate | −$0.06 |
| EPS surprise | −61.39% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1129928/000112992825000089/q32025form6-k.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 12, 2025 | −$0.06 | −$0.10 | -61.39% | — | — |
| Q2 2025 | Aug 8, 2025 | −$0.07 | −$0.05 | 30.08% | — | — |
| Q1 2025 | May 14, 2025 | −$0.07 | −$0.06 | 17.82% | — | — |
| Q4 2024 | Mar 7, 2025 | −$0.09 | −$0.07 | 20.09% | — | — |
| Q3 2024 | Nov 12, 2024 | −$0.07 | −$0.09 | -16.98% | — | — |
| Q2 2024 | Aug 1, 2024 | −$0.07 | −$0.07 | 3.48% | — | — |
| Q1 2024 | May 9, 2024 | −$0.08 | −$0.07 | 20.89% | — | — |
| Q4 2023 | Mar 7, 2024 | −$0.11 | −$0.04 | 65.52% | — | — |
| Q3 2023 | Nov 3, 2023 | −$0.08 | −$0.10 | -29.78% | — | — |
| Q2 2023 | Aug 14, 2023 | −$0.09 | −$0.09 | -1.14% | — | — |
| Q1 2023 | May 5, 2023 | −$0.09 | −$0.07 | 20.85% | — | — |
| Q4 2022 | Mar 3, 2023 | −$0.07 | −$0.10 | -43.24% | — | — |
| Q3 2022 | Nov 7, 2022 | −$0.08 | −$0.06 | 29.40% | — | — |
| Q2 2022 | Aug 11, 2022 | −$0.08 | −$0.07 | 13.27% | — | — |
| Q1 2022 | May 5, 2022 | −$0.11 | −$0.09 | 17.67% | — | — |
| Q4 2021 | Mar 3, 2022 | −$0.10 | −$0.11 | -8.72% | — | — |
| Q3 2021 | Nov 5, 2021 | −$0.11 | −$0.07 | 36.04% | — | — |
| Q2 2021 | Aug 6, 2021 | −$0.10 | −$0.10 | -4.66% | — | — |
| Q1 2021 | May 7, 2021 | −$0.14 | −$0.11 | 22.01% | — | — |
| Q4 2020 | Mar 5, 2021 | −$0.12 | −$0.17 | -42.06% | — | — |

## Frequently Asked Questions

### When did Oncolytics Biotech (ONCY) last report earnings?

Oncolytics Biotech last reported on Nov 12, 2025, covering fiscal Q3 2025.

### Did ONCY beat earnings estimates?

No. Oncolytics Biotech reported EPS of −$0.10 for Q3 2025 against a −$0.06 estimate — a 61.39% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).